Benchmark Co. analyst Bill Sutherland has reiterated their bullish stance on HURN stock, giving a Buy rating today.
Bill Sutherland has given his Buy rating due to a combination of factors that highlight Huron Consulting’s promising future. The company’s recent analyst presentation outlined a robust three-year plan, which includes sustained low double-digit revenue growth and annual EBITDA margin expansion. Huron aims to double its adjusted EPS by 2029 and maintain a strong free cash flow conversion rate, with capital allocation balanced between share repurchases and strategic acquisitions.
Huron’s competitive strengths lie in its leadership in the Healthcare and Education sectors, broad service capabilities, and a balanced mix of offerings that can withstand various economic conditions. The company also benefits from high employee retention and significant equity incentives. Management’s guidance for 2025 suggests a conservative outlook, with manageable EBITDA margin expansion, further supporting the Buy rating. These factors, coupled with Huron’s strategic goals and market positioning, contribute to Sutherland’s positive assessment.
Sutherland covers the Healthcare sector, focusing on stocks such as AMN Healthcare Services, Cross Country Healthcare, and Healthcare Services. According to TipRanks, Sutherland has an average return of -6.0% and a 36.05% success rate on recommended stocks.